Literature DB >> 10067896

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

L Ulloa1, J Doody, J Massagué.   

Abstract

Transforming growth factor-beta (TGF-beta) and interferon-gamma (IFN-gamma) have opposite effects on diverse cellular functions, but the basis for this antagonism is not known. TGF-beta signals through a receptor serine kinase that phosphorylates and activates the transcription factors Smads 2 and 3, whereas the IFN-gamma receptor and its associated protein tyrosine kinase Jak1 mediate phosphorylation and activation of the transcription factor Stat1. Here we present a basis for the integration of TGF-beta and IFN-gamma signals. IFN-gamma inhibits the TGF beta-induced phosphorylation of Smad3 and its attendant events, namely, the association of Smad3 with Smad4, the accumulation of Smad3 in the nucleus, and the activation of TGFbeta-responsive genes. Acting through Jak1 and Stat1, IFN-gamma induces the expression of Smad7, an antagonistic SMAD, which prevents the interaction of Smad3 with the TGF-beta receptor. The results indicate a mechanism of transmodulation between the STAT and SMAD signal-transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067896     DOI: 10.1038/17826

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  204 in total

Review 1.  Cytokines in experimental colitis.

Authors:  P Garside
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 2.  TGF-beta-mediated control of allergen-specific T-cell responses.

Authors:  Carsten B Schmidt-Weber; Steffen Kunzmann; Kurt Blaser
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

3.  TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.

Authors:  C Fiocchi
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

Authors:  M Bitzer; G von Gersdorff; D Liang; A Dominguez-Rosales; A A Beg; M Rojkind; E P Böttinger
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

5.  Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Authors:  Sumedha G Penheiter; Hugh Mitchell; Nandor Garamszegi; Maryanne Edens; Jules J E Doré; Edward B Leof
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

6.  Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells.

Authors:  Huilin Qi; Dean J Aguiar; Shelly M Williams; Alison La Pean; Wei Pan; Catherine M Verfaillie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

Review 7.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

8.  Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma.

Authors:  Masato Komai; Hiroyuki Tanaka; Taisei Masuda; Koichi Nagao; Masayuki Ishizaki; Masatsugu Sawada; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

9.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

10.  Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).

Authors:  Rama Krishna Gurram; Weshely Kujur; Sudeep K Maurya; Javed N Agrewala
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.